Pharmodynamics

About Us

We are a drug development company that is using existing generic or OTC medications in unique combinations and formulations to produce and market drugs that are more effective than the individual generics.

Our experienced development team plans to have two blockbuster drugs on the market within two years. These drugs will provide significant improvement in outcome results for common ailments without common side effects. These first two drugs have already been formulated and testing has begun. They will provide positive cash flow for the development of additional new therapies using reformulatied or combinations of existing drugs for new therapies.

Dr. Spivak has a vast experience in biochemical research, clinical medicine and management.
He synthesized and helped patent a non-sedating antihistame while at Schering Corp. as a research chemist.
As a research fellow at the Harvard Medical School he worked on the physical chemistry of bilirubin and bile salts.
He served as the Principal Investigator on an NIH grant for eight years .
He served as Chief of Pediatric GI and Nutrition at both New York Hospital and Montefiore Medical Center.
He was President and founder of an Internet company that had over $4 million in annual sales.
He is currently a Clinical Professor of Pediatrics at Cornell University Medical College in NY.
He devotes his full time to Pharmodynamics.
He has already developed two prototype drugs for Pharmodynamics that should be ready for testing soon.

For inquiries concerning Pharmodynamics, Inc. contact

William Spivak, M.D.

Tel: 212-369-7700

Fax: 888-971-2310